Art. 69 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 9×
1.

In addition to the clear mention of the words ‘homeopathic medicinal product’, the labelling and, where appropriate, the package insert for the medicinal products referred to in Article 14(1) shall bear the following, and no other, information:

the scientific name of the stock or stocks followed by the degree of dilution, making use of the symbols of the pharmacopoeia used in accordance with Article 1(5); if the homeopathic medicinal product is composed of two or more stocks, the scientific names of the stocks on the labelling may be supplemented by an invented name,

name and address of the registration holder and, where appropriate, of the manufacturer,

method of administration and, if necessary, route,

expiry date, in clear terms (month, year),

pharmaceutical form,

contents of the sales presentation,

special storage precautions, if any,

a special warning if necessary for the medicinal product,

manufacturer's batch number,

registration number,

‘homeopathic medicinal product without approved therapeutic indications’,

a warning advising the user to consult a doctor if the symptoms persist.

2.

Notwithstanding paragraph 1, Member States may require the use of certain types of labelling in order to show:

the price of the medicinal product,

the conditions for refunds by social security bodies.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Eighth Chamber) of 23 April 2020. Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik DeutscDecisioninterprets

    These requests for a preliminary ruling concern the interpretation of Articles 62 and 69 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for …

    23 Apr 2020 · 62019CJ0101

  • BVerwG, EuGH-Vorlage vom 8. November 2018 - 3 C 2/17Decision

    … Oktober 2012 (ABl. L 299 vom 27. Oktober 2012 S. 1) geänderten Fassung vorgelegt: 1. Enthält Art. 69 der Richtlinie 2001/83/EG abschließende Vorgaben zum zulässigen Inhalt der Packungsbeilage der in Art. 14 Abs. 1 genannten …

    8 Nov 2018 · WBRE201900111

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    According to Article 69(2) of that directive: ‘Notwithstanding paragraph 1, Member States may require the use of certain types of labelling in order to show: the price of the medicinal product, the conditions for refunds by social …

    17 Nov 2022 · 62020CJ0224

  • BGH, Beschluss vom 16. Juli 2009 - I ZR 223/06Decision

    … 2001/83/EG gelten die Bestimmungen des Titels VIII allerdings nicht für die Etikettierung und die Packungsbeilage (Art. 54 bis 69). Danach stellen Informationen auf dem Etikett und in der Packungsbeilage freilich nur dann keine Werbung …

    16 Jul 2009 · I_ZR_223-06

  • Opinion of Advocate General Campos Sánchez-Bordona delivered on 30 January 2025. SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co.KG v AstrDecision

    Asked regarding that expression, the Court ruled out the inclusion, in the package leaflet of a homeopathic medicinal product, of indications relating to posology, considering them capable of misleading the user regarding the …

    30 Jan 2025 · 62023CC0618

  • Opinion of Advocate General Trstenjak delivered on 24 November 2010. MSD Sharp & Dohme GmbH v Merckle GmbH.Decision

    … der Richtlinie 2001/83, dass die Bestimmungen ihres Titels VIII nicht für die Etikettierung und die Packungsbeilage (Art. 54 bis 69) gälten. Danach stellten Informationen auf dem Etikett und in der Packungsbeilage jedoch nur dann keine …

    24 Nov 2010 · 62009CC0316

  • BVerwG, Urteil vom 10. August 2020 - 3 C 10/20 u.a.Decision

    10 Aug 2020 · WBRE202000706

  • BVerwG, EuGH-Vorlage vom 8. November 2018 - 3 C 3/17Decision

    … Oktober 2012 (ABl. L 299 vom 27. Oktober 2012 S. 1) geänderten Fassung vorgelegt: 1. Enthält Art. 69 der Richtlinie 2001/83/EG abschließende Vorgaben zum zulässigen Inhalt der Packungsbeilage der in Art. 14 Abs. 1 genannten …

    8 Nov 2018 · WBRE201900110